Assembly of hepatitis e vaccine by ': In situ ' growth of gold clusters as nano-adjuvants: An efficient way to enhance the immune responses of vaccination

Hai Wang, Yanping Ding, Shishuai Su, Duojia Meng, Ayeesha Mujeeb, Yan Wu, Guangjun Nie

Research output: Contribution to journalArticle

8 Scopus citations

Abstract

Vaccine-based immunotherapy plays an integral role in the development of present and future clinical therapies. Despite the success, there is still a great need to improve the efficiency and safety of vaccines. Nanoparticles have been widely used for improving the efficacy of vaccines by encapsulating the vaccines or using nanoparticles as immune adjuvants. However, the methods for the preparation of nanoparticles are complex with a relatively low encapsulation efficiency of protein vaccine inside the nanocarriers and/or undefined physiochemical properties. Here, we report a new method of preparation of a vaccine by the "in situ" growth of gold clusters in the hepatitis E vaccine (HEVA). The gold cluster grafted HEVA (HEVA/Au) can be easily obtained and there is no loss of HEVA during the preparation process. More importantly, the "in situ" prepared HEVA/Au can not only enhance its immune responses in vivo, but also reduce the potential toxicity of HEVA. Furthermore, the intrinsic fluorescence of gold clusters enables the HEVA to be traceable, which may open a way to track the dynamic behavior of vaccines and further help to optimize an individual therapeutic regimen for immunotherapy.

Original languageEnglish (US)
Pages (from-to)394-398
Number of pages5
JournalNanoscale Horizons
Volume1
Issue number5
DOIs
StatePublished - Sep 2016

ASJC Scopus subject areas

  • Materials Science(all)

Fingerprint Dive into the research topics of 'Assembly of hepatitis e vaccine by ': In situ ' growth of gold clusters as nano-adjuvants: An efficient way to enhance the immune responses of vaccination'. Together they form a unique fingerprint.

Cite this